Heart News and Research

RSS

Microplastics found to bioaccumulate in every organ of mice

Plastics - in particular, microplastics - are among the most pervasive pollutants on the planet, finding their way into the air, water systems and food chains around the world.

29 Aug 2023

An update on the health benefits of olive oil

Researchers summarize recent evidence on the clinical impact of olive oil on human health.

29 Aug 2023

How can different diets combined with salt restriction alleviate high blood pressure and hypertension?

A recent study conducted a clinical trial to compare the popular diets, namely, the Dietary Approaches to Stop Hypertension and the Mediterranean diet, in combination with a salt-restricting strategy for reducing high blood pressure and hypertension.

29 Aug 2023

Inflammatory diets raise dementia and Alzheimer's risk

This research study links higher Dietary Inflammatory Index (DII) scores to an increased risk of developing dementia, specifically Alzheimer's disease. The findings suggest that anti-inflammatory diets may offer a preventive strategy for dementia, underlining the need for further research to validate these associations.

28 Aug 2023

lncRNAs play role in malaria parasite's life cycle, study finds

The mosquito-borne infectious disease malaria resulted in about 241 million clinical episodes and 627,000 deaths in 2020.

28 Aug 2023

Unlocking ACE2: The enzyme that links COVID-19, heart disease, and diabetes

A recent study in the Journal of Biomedical Science examines the critical role of ACE2, an enzyme involved in blood volume and electrolyte balance, in chronic diseases like cardiovascular conditions, diabetes, and COVID-19. The research suggests that ACE2 could serve as both a disease severity biomarker and a therapeutic target.

28 Aug 2023

Study highlights the economic burden of cardiovascular diseases in the European Union

Cardiovascular disease (CVD) cost the EU an estimated €282 billion in 2021, according to late breaking research presented at ESC Congress 2023.

28 Aug 2023

Trial addresses the optimal timing for complete revascularization of patients with STEMI and multivessel disease

Immediate multivessel percutaneous coronary intervention (PCI) is non-inferior to staged multivessel PCI for reducing death and ischaemic events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

ECLS does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock

Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock who are scheduled for early revascularization, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Study shows efficacy and safety of OCT-guided strategy for percutaneous coronary intervention

Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Acoramidis shows potential to be effective, safe treatment for transthyretin amyloid cardiomyopathy

Acoramidis improves outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared with placebo, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Ablation more effective than medical therapy in patients with end-stage heart failure, study shows

Atrial fibrillation ablation is associated with lower rates of death, urgent heart transplantation or left ventricular assist device (LVAD) implantation compared with medical therapy in patients with end-stage heart failure, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

First oral treatment for Lipoprotein(a) shows significant cholesterol reduction

A new drug offers a breakthrough world first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke, announced today by study lead Professor Stephen Nicholls, Director of the Monash University's Victorian Heart Institute and Victorian Heart Hospital.

28 Aug 2023

Obese adults with ARDS may benefit from ECMO

A National Institutes of Health-supported study suggests that adults with obesity may benefit from the use of extracorporeal membrane oxygenation (ECMO), an advanced form of breathing support, when in intensive care for respiratory failure.

28 Aug 2023

CRT-D upgrade reduces morbidity and mortality in HFrEF patients with RV pacing

Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable cardioverter-defibrillator (ICD) in select patients with heart failure and reduced ejection fraction (HFrEF) and intermittent or permanent right ventricular (RV) pacing, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Intravenous ferric carboxymaltose linked to lower risk of heart failure hospitalizations in iron-deficient patients

In iron-deficient patients with heart failure and reduced or mildly reduced left ventricular ejection fraction, intravenous ferric carboxymaltose (FCM) is associated with a reduced risk of the composite outcome of total cardiovascular hospitalization and cardiovascular death through 52 weeks compared with placebo, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Heart News and Research

Microplastics found to bioaccumulate in every organ of mice

An update on the health benefits of olive oil

How can different diets combined with salt restriction alleviate high blood pressure and hypertension?

Inflammatory diets raise dementia and Alzheimer's risk

lncRNAs play role in malaria parasite's life cycle, study finds

Unlocking ACE2: The enzyme that links COVID-19, heart disease, and diabetes

Study highlights the economic burden of cardiovascular diseases in the European Union

Trial addresses the optimal timing for complete revascularization of patients with STEMI and multivessel disease

ECLS does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Study shows efficacy and safety of OCT-guided strategy for percutaneous coronary intervention

Acoramidis shows potential to be effective, safe treatment for transthyretin amyloid cardiomyopathy

Ablation more effective than medical therapy in patients with end-stage heart failure, study shows

First oral treatment for Lipoprotein(a) shows significant cholesterol reduction

Obese adults with ARDS may benefit from ECMO

CRT-D upgrade reduces morbidity and mortality in HFrEF patients with RV pacing

Intravenous ferric carboxymaltose linked to lower risk of heart failure hospitalizations in iron-deficient patients

PROFID EHRA trial to assess the potential benefit of ICD therapy in myocardial infarction survivors

The potential of targeting mitochondria-associated programmed cell death for age-related disease treatment

Trial evaluates behavioral and psychological interventions to reduce cardiotoxic effects of breast cancer treatment

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News